Compare Banco Bilbao Vizcaya Argentaria SA (BBVA) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Banco Bilbao Vizcaya Argentaria SA vs Revvity Inc — how do they compare? Banco Bilbao Vizcaya Argentaria SA trades at $28.75 (market cap $157.51B), while Revvity Inc trades at $116.5 (market cap $12.91B). The key difference: Banco Bilbao Vizcaya Argentaria SA is far larger — about 12.2× Revvity Inc's market cap, and Banco Bilbao Vizcaya Argentaria SA pays the higher dividend (3.8%). Which is the better fit depends on your goals.
| BBVA | RVTY | |
|---|---|---|
Market Cap | $157.51B | $12.91B |
Sector | Financials | Technology |
52-Week High | $28.50 | $117.75 |
52-Week Low | $17.96 | $82.26 |
Dividend Yield | 3.8% | 0.24% |
Enterprise Value | — | $15.23B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Banco Bilbao Vizcaya Argentaria SA
Despite its Spanish origins, BBVA generates three quarters of its profits in emerging markets, especially Mexico that contributes nearly half of BBVA's net profit. BBVA is overwhelmingly a retail and commercial bank with corporate and investment banking forming a smaller part of the overall business.
Read more on BBVA →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
